台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
旭富 (4119)籌碼相關-元大-蘆洲 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-蘆洲 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/100.286.80186.0085.80-0.8259-0.31%
2024/12/17190.3000.0090.2012430.41%
2024/12/1300.00190.5090.60-1238-0.42%
2024/12/0900.00795.0393.40-7224-3.11%
2024/12/05297.5000.0097.4022180.91%
2024/12/04697.9200.0097.8062162.77%
2024/12/0300.00498.4097.80-4216-1.84%
2024/11/28194.7000.0095.0011970.51%
2024/11/2000.00198.1097.80-1172-0.58%
2024/11/1900.00496.5096.10-4155-2.57%
2024/11/1400.001094.7094.90-10142-7.02%
2024/11/11194.10293.7093.30-1112-0.89%
2024/11/060.389.70389.2089.40-2.796-2.81%
2024/10/15190.0000.0090.5011300.77%
2024/10/0900.00291.4091.40-2135-1.48%
2024/10/08292.1000.0092.0021331.49%
2024/09/16188.0000.0087.8011520.66%
2024/09/0300.00188.4088.50-1164-0.61%
2024/09/020.388.4000.0088.500.31680.17%
2024/08/3000.000.188.9088.40-0.1171-0.08%
2024/08/29088.5000.0088.5001720.02%
2024/08/21289.0000.0089.4021801.11%
2024/08/201.389.6000.0089.201.31810.70%
2024/08/0600.000.288.5288.90-0.2218-0.07%
2024/08/0500.001486.7386.60-14214-6.53%
2024/08/01191.3000.0092.2012040.49%
2024/07/31190.7000.0091.2012040.49%
2024/07/1800.001.792.3892.70-1.7199-0.85%
2024/07/16792.59292.5092.7051972.53%
2024/07/15292.2000.0092.8022020.99%
2024/07/1200.00291.8091.80-2200-1.00%
2024/07/0900.000.191.5091.80-0.1205-0.05%
2024/07/05191.2000.0091.3012030.49%
2024/07/041.191.21791.2091.20-5.9205-2.89%
2024/07/021.191.312590.8991.20-23.9206-11.57%
2024/07/0100.00689.7789.90-6203-2.95%
2024/06/250.289.5000.0089.500.22040.10%
2024/06/2100.00190.3090.30-1206-0.49%
2024/06/20190.0000.0090.2012060.48%
2024/06/17190.90191.1090.8002080.00%
2024/06/14190.0000.0090.1012100.47%
2024/06/130.590.20790.2090.00-6.5212-3.07%
2024/06/11290.8500.0090.2022140.93%
2024/06/0700.00192.8093.10-1216-0.46%
2024/05/3000.00392.6092.50-3230-1.30%
2024/05/2900.00592.6092.30-5234-2.13%
2024/05/2800.00192.8092.50-1235-0.42%
2024/05/2700.00193.0093.10-1234-0.43%
2024/05/23191.6000.0091.3012350.42%
2024/05/177.293.2900.0093.907.22303.11%
2024/05/1500.00190.9091.50-1222-0.45%
2024/05/14191.8000.0091.2012290.44%
2024/05/1000.00190.9090.90-1240-0.42%
2024/04/19186.7000.0086.4012540.39%
2024/04/171188.4700.0088.40112494.41%
2024/04/02489.4500.0088.6042591.54%
2024/03/22187.30287.3087.60-1265-0.38%
2024/03/1500.000.788.0087.40-0.7285-0.24%
2024/03/1400.00088.5087.2002860.00%
2024/03/13188.0000.0087.9012850.35%
2024/03/1200.00189.1089.00-1278-0.36%
2024/03/08192.1000.0090.4012730.37%
2024/03/07190.0000.0090.5012690.37%
2024/03/04290.8500.0090.9022740.73%
2024/02/29191.0000.0091.2012810.36%
2024/02/27191.3000.0091.5012810.36%
2024/02/2300.00190.9091.10-1283-0.35%
2024/02/19191.6000.0091.5012850.35%
2024/02/15289.4000.0089.9022930.68%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章